Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 98 entries
View as:

Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03909412 Org: User:
Start: 10/08/19 End: 10/31/25 Due: 10/31/26

Dose Finding Study of Ibrutinib Plus Lenalidomide / Rituximab in Relapsed or Refractory Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02446236 Org: User:
Start: 06/18/15 End: 10/31/25 Due: 10/31/26

Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05715229 Org: User:
Start: 09/29/23 End: 04/28/26 Due: 04/28/27

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004900 Org: User:
Start: 10/31/99 End: 08/31/04 Due: 08/31/05

A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02624804 Org: User:
Start: 06/27/17 End: 03/11/24 Due: 03/11/25

Central Venous Access Study

Phase: N/A Priority: Normal
NCT ID: NCT03480542 Org: User:
Start: 04/11/17 End: 04/07/22 Due: 04/07/23

In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus

Phase: N/A Priority: Normal
NCT ID: NCT01453140 Org: User:
Start: 08/31/11 End: 07/31/12 Due: 07/31/13

Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)

Phase: N/A Priority: Normal
NCT ID: NCT05651945 Org: User:
Start: 01/20/23 End: 01/20/31 Due: 01/20/32

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05657990 Org: User:
Start: 04/03/23 End: 12/31/26 Due: 12/31/27

PET-CT Scans in Healthy Volunteers After Flu Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT00769002 Org: User:
Start: 09/30/08 End: 08/31/11 Due: 08/31/12

HUMC 1612: Optune NovoTTF-200A System

Phase: N/A Priority: Normal
NCT ID: NCT03128047 Org: User:
Start: 04/06/17 End: 07/08/26 Due: 07/08/27

ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes

Phase: N/A Priority: Normal
NCT ID: NCT04794686 Org: User:
Start: 07/12/20 End: 07/12/30 Due: 07/12/31

Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection

Phase: N/A Priority: Normal
NCT ID: NCT04456413 Org: User:
Start: 11/06/20 End: 05/04/21 Due: 05/04/22

Correlation Between CPAP Compliance and Food Intake Timing

Phase: N/A Priority: Normal
NCT ID: NCT01851811 Org: User:
Start: 10/31/08 End: 02/28/09 Due: 02/28/10

Pembrolizumab + Lenalidomide Post Autologous Stem Cell Transplant (ASCT) in High-risk Multiple Myeloma (MM)

Phase: N/A Priority: Normal
NCT ID: NCT02906332 Org: User:
Start: 12/12/16 End: 05/31/22 Due: 05/31/23

NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03232424 Org: User:
Start: 07/26/17 End: 12/07/22 Due: 12/07/23

Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT02846376 Org: User:
Start: 03/08/19 End: 12/21/23 Due: 12/21/24

Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older

Phase: N/A Priority: Normal
NCT ID: NCT01453088 Org: User:
Start: 06/24/10 End: 05/01/22 Due: 05/01/23

Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide

Phase: N/A Priority: Normal
NCT ID: NCT01723839 Org: User:
Start: 02/22/12 End: 06/08/21 Due: 06/08/22

A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00464178 Org: User:
Start: 04/30/07 End: 02/28/09 Due: 02/28/10

The "Peripheral Access Utilizing Sonographic Evaluation" Study

Phase: N/A Priority: Normal
NCT ID: NCT02360163 Org: User:
Start: 02/28/15 End: 01/19/17 Due: 01/19/18

Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT

Phase: N/A Priority: Normal
NCT ID: NCT01242267 Org: User:
Start: 05/11/10 End: 01/20/16 Due: 01/20/17

Culturally Tailored Diabetes Education on Self-Management of Adult Hispanic Males With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT06897618 Org: User:
Start: 08/01/25 End: 07/31/26 Due: 07/31/27

Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients

Phase: N/A Priority: Normal
NCT ID: NCT05776953 Org: User:
Start: 12/21/23 End: 12/20/25 Due: 12/20/26

OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression

Phase: N/A Priority: Normal
NCT ID: NCT06991166 Org: User:
Start: 08/01/25 End: 08/01/27 Due: 08/01/28